WHO Recommends Against GLP-1s For Young Kids—Amid Wegovy Trial For 6 Year Olds
Despite a nearly 600% surge in adolescent GLP-1 prescriptions, the WHO says they may pose critical safety risks to growing bodies.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.